Clinical Trial Update: AF Substrate Mapping and Guided Ablation [NA]

View source ↗

Summary

Clinical trial update on AF substrate mapping and guided ablation for persistent atrial fibrillation; completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Atrial Fibrillation

Drugs mentioned

• Abbott Medical Devices

Snippet

Sponsor: Abbott Medical Devices | Conditions: Persistent Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2019-07-05